Search Results
Your search for ,her matches 3340 pages
Showing 1251 - 1300Late-Stage Cancer Diagnoses After Massachusetts Health Insurance Reform Law
Advanced-stage cancer diagnoses declined following health insurance expansion in Massachusetts, likely due to increased access to screening and diagnostic services that identified cancers earlier, according to new research published by Sabik et al in the journal Medical Care. The analysis...
How Real-World Data Can Help Contextualize New Treatments in Older Patients
Consider a patient who is referred for neoadjuvant therapy for stage IIIA, HER2-positive breast cancer. She is otherwise healthy, with no significant medical history, an Eastern Cooperative Oncology Group performance status of 0, unremarkable baseline labs, and a left-ventricular ejection fraction...
APHINITY Update Supports Benefit of Pertuzumab-Based Triplet in Early HER2-Positive, Node-Positive Breast Cancer
Six-year follow-up of the APHINITY trial found a modest, but not statistically significant, overall survival benefit for the addition of pertuzumab to chemotherapy plus trastuzumab vs chemotherapy/trastuzumab as adjuvant therapy in patients with early HER2-positive breast cancer. The benefit was...
Elizabeth Fox, MD, Named Senior Vice President of Clinical Trials Research at St. Jude
St. Jude Children’s Research Hospital announced recently that Elizabeth Fox, MD, has been named Senior Vice President of Clinical Trials Research. In this role, Dr. Fox will oversee clinical trials research administration and strategy at St. Jude. She will also serve as Associate Director for...
Dolores Hambardzumyan, PhD, MBA, Joins Neurosurgery Faculty at Mount Sinai
Dolores Hambardzumyan, PhD, MBA, has been appointed Senior Faculty in the Department of Neurosurgery and a member of The Tisch Cancer Institute at the Icahn School of Medicine at Mount Sinai. Her research focuses on developing novel therapeutic pathways for the treatment of glioblastoma. She is...
Cleveland Clinic Taussig Cancer Institute Recognizes New Staff, New Appointments
In a news release issued by Cleveland Clinic Taussig Cancer Institute, the following announcements were made. Center Adds Clinical Psychologist to Staff Melissa Walt, PsyD, a clinical psychologist, recently joined the Cleveland Clinic Taussig Cancer Institute. She will focus on the psychological...
Emerging Fertoprotective Therapeutic Options for Female Fertility Preservation
The trend toward delayed childbearing has meant that many women who plan to have children may be childless at the time they are diagnosed with cancer. The number of these women is likely to further increase concurrently with the increase in cancer survivors, making “the focus on fertility...
ASH Honors Member of Congress and Leaders of NIDDK and NCI
The American Society of Hematology (ASH) recognized representative Tom Cole (R–OK); the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Hematology and Training Program Director Terry Bishop, PhD; and National Cancer Institute (NCI) Program Director William Merritt, PhD,...
A Caregiver’s Tale of Struggle and Lingering Questions
The role of caregiver in the cancer scenario is complicated by various emotions and circumstances beyond the control of the caregiver and the person with cancer. Caregiver stress occurs when there isn’t the time to do all that’s asked or expected of one. Caregiver stress evolves into burnout when...
Forbes Magazine Names 2020 Class of 30 Under 30, Including Honorees in Science and Health Care
Forbes magazine released the ninth annual “30 Under 30” list Class of 2020 in December 2019, featuring the newest group of 600 young entrepreneurs, scientists, and innovative individuals who were recognized for their extraordinary accomplishments at early ages. A total of 30 honorees were selected...
Seven Haircuts
The ASCO Post is pleased to reproduce installments of the Art of Oncology as published previously in the Journal of Clinical Oncology. These articles focus on the experience of suffering from cancer or of caring for people diagnosed with cancer, and they include narratives, topical essays,...
Radiation Oncologist Felix Y. Feng, MD, Strives for Balance Between Work and Family Life
In this installment of the Living a Full Life series, guest editor Jame Abraham, MD, FACP, spoke with Felix Y. Feng, MD, Professor of Radiation Oncology, Urology, and Medicine; George and Judy Marcus Distinguished Professor; Vice Chair of Translational Research in the Department of Radiation...
Stephanie Lee, MD, MPH, Begins Term as ASH President
Stephanie Lee, MD, MPH, an expert in graft-vs-host disease as well as blood and bone marrow diseases, will serve as President of the American Society of Hematology (ASH) for a 1-long term through December 2020. Dr. Lee is a member and Associate Director of the Clinical Research Division at Fred...
American Cancer Society Welcomes Three New Members to the Board of Directors
The American Cancer Society (ACS) has announced three new members to the Board of Directors, effective January 1, 2020. Joining the ACS board are Katie Eccles, Patrick Geraghty, and Oyebode Taiwo, MD, MPH. The ACS Board of Directors consists of 21 members, which include 5 officers (elected for a ...
Residual Cancer Burden Is Prognostic of Outcomes Across Breast Cancer Subtypes
Residual cancer burden after neoadjuvant chemotherapy can accurately predict disease recurrence and survival across all breast cancer subtypes, according to the findings from a meta-analysis presented at the 2019 San Antonio Breast Cancer Symposium by W. Fraser Symmans, MD, Professor and Director...
Higher 21-Gene Recurrence Score May Be Associated With Increased Risk of Locoregional Recurrence in Patients With Breast Cancer
A new study shows that a test physicians commonly use to guide chemotherapy for patients with breast cancer after surgery may also help them decide whether radiation therapy may be of benefit. Results published by Wendy A. Woodward, MD, PhD, and colleagues in JAMA Oncology suggest patients with an...
Transplantation Specialist Karen Ballen, MD, Treasures Long-Term Connections With Her Patients
Karen Ballen, MD, an international expert in stem cell transplantation, particularly for patients who have a difficult time finding a donor, was born and reared in the Bronx in a family that encouraged academic and professional pursuits. “My grandfather was an old-fashioned pediatrician who made...
Does Statin Use Increase Overall Survival in Patients With Colorectal Cancer?
About 40 million adults in the United States take a statin to lower their cholesterol and reduce the risk for heart disease—but they may also be getting an added anticancer benefit, a growing body of evidence suggests. According to research presented at the American Heart Association’s Scientific...
Final Answers
Emily Johnston, MD, MS, thinks about death a lot. “I wish we would stop saying people ‘lost a battle’ with cancer when someone dies,” she said. Dr. Johnston specializes in pediatric oncology at Children’s of Alabama hospital. Conquering cancer, she believes, doesn’t simply mean surviving it—it...
Time to Treatment Is a Priority
Dr. Smith called us on a Tuesday afternoon. “I have a patient who has an abnormal mammogram showing a large mass. I’m suspecting cancer and am referring her to you for diagnosis and treatment. She’s very anxious. I hope you can help.” We were able to get Dr. Smith’s patient in the next day for...
The Rise and Fall of Tobacco Products in the United States
It was a press conference on a cold Saturday in January 1964 that had garnered international attention, but the trappings were those of a secret government meeting, behind locked doors secured by uniformed guards. To the chagrin of the reporters, “no smoking” signs had been hastily posted around...
How to Give Effective Presentation Feedback
Giving an effective scientific presentation, like all public speaking, is an acquired skill that takes practice to perfect. When delivered successfully, an oral presentation can be an invaluable opportunity to showcase your latest research results among your colleagues and peers. It can also...
Lung Cancer Expert Julie R. Brahmer, MD, MSc, Was an Early Believer in Immunotherapy—and Still Is
Lung cancer specialist Julie R. Brahmer, MD, MSc, comes from a long line of Midwest farmers who still run a family operation. “I’m originally from what I would call the middle of nowhere in Nebraska. My father is a sixth-generation farmer, and my mother is a nurse. I was inclined toward medicine at ...
Ilaria Iacobucci, PhD, on AML and MDS: Moving Beyond Gene Panel–Based Classifications
Ilaria Iacobucci, PhD, of St. Jude Children’s Research Hospital, discusses her work to more accurately define mutation subtypes in acute myeloid leukemia and myelodysplastic syndromes, as well as the implications for diagnosis, prognosis, and treatment (Abstract LBA-4 ).
Having Cancer Should Not Make You Homeless
In the spring of 2005, I was launching a new career as a sales consultant for a startup graphics company and wanted to cross off a few essential things on my to-do list, including getting my annual mammogram and physical, before I started my new job. Although I was surprised when I got a call from ...
Carolyn C. Meltzer, MD, Joins Board of Directors for RSNA
Carolyn C. Meltzer, MD, neuroradiologist, nuclear physician, and leader in organized radiology, joined the Radiological Society of North America (RSNA) Board of Directors earlier this month at the Society’s annual meeting in Chicago. She will serve as the board liaison for science. “I am delighted ...
An Early Interest in Biology and People Led to a Career in Oncology for Nina Shah, MD
Multiple myeloma expert Nina Shah, MD, was born and reared in the Northeast. During grade school, she developed a passion for science that would lead to an early decision to pursue a career in medicine. “My ninth-grade biology class really got me interested in human biology, and that’s when I...
Mary Jo Turk, PhD, Named O. Ross McIntyre, MD, Professor at Dartmouth College
Mary Jo Turk, PhD, has been named the O. Ross McIntyre, MD, Professor at the Geisel School of Medicine at Dartmouth College. Professor of Microbiology and Immunology and Co-Director of the Immunology and Cancer Immunotherapy Program at Dartmouth’s Norris Cotton Cancer Center, Dr. Turk joined the...
JOP Editor-in-Chief Brings Value-Based Care to Journal’s Forefront
In January 2019, Linda D. Bosserman, MD, FACP, FASCO, began her tenure as Editor-in-Chief of the Journal of Oncology Practice (JOP). An Assistant Clinical Professor and staff physician at City of Hope, Dr. Bosserman has served on the ASCO Board of Directors and was a founding member of the TAPUR...
Elaine Fuchs, PhD, to Present Annual Block Lecture at The Ohio State University Comprehensive Cancer Center
Elaine Fuchs, PhD, is the recipient of the 24th annual Herbert and Maxine Block Memorial Lectureship Award for Distinguished Achievement in Cancer. It is given annually to a renowned cancer researcher who is invited to The Ohio State University Comprehensive Cancer Center–Arthur G. James Cancer...
2019 Advanced Breast Cancer Award Goes to Fatima Cardoso, MD
The European School of Oncology (ESO), together with the Advanced Breast Cancer Global Alliance, bestowed the 2019 Advanced Breast Cancer Award upon Professor Fatima Cardoso, MD, Director of the Breast Unit of the Champalimaud Clinical Centre in Lisbon, “in recognition of her foresight in...
Biomarker-Driven Treatment Selection for Prostate and Other Genitourinary Cancers
As the Nobel Laureate Bob Dylan wrote, “The times they are a-changin’.” Heather Cheng, MD, PhD, Associate Professor, University of Washington, Associate Member, Fred Hutchinson Cancer Research Center, and Director, Seattle Cancer Care Alliance, Prostate Cancer Genetics Clinic, quoted this line in...
Emerging Alternatives in the Third-Line Setting for Metastatic HER2-Positive Breast Cancer
In the post-trastuzumab era, a number of U.S. Food and Drug Administration (FDA)-approved targeted agents for metastatic HER2-positive breast cancer are available, but there is no preferred option for third-line treatment and beyond. At the 2019 Chemotherapy Foundation Symposium, Shanu Modi, MD,...
Your Stories: Behind the Breakthroughs
When Desirée Walker was diagnosed with breast cancer, she considered not treating it—but more frightening to her than the side effects of chemotherapy was missing the chance to watch her children grow. In “Mother Knows Best”—part of the Your Stories Featured Conversations series from Conquer...
Using the Nobel Prize to Champion Curiosity-Driven Research in Cancer
William G. Kaelin, Jr, MD, Sidney Farber Professor of Medicine and Howard Hughes Medical Institute Investigator at Dana-Farber Cancer Institute and Brigham and Women’s Hospital, Harvard Medical School, admits that early in his research career, he and his late wife, Carolyn, would have fun...
Adetokunbo 'Toks' Oluwasanjo, MD, Joins Florida Group
Medical oncologist/hematologist Adetokunbo ‘Toks’ Oluwasanjo, MD, has joined Florida Cancer Specialists (FCS) in the new FCS Lake City office. For 3 years, she served on the faculty in the Department of Medicine of the Reading Health System (now Tower Health System). Dr. Toks received her medical...
Despite Challenges, Pioneer in CT Screening for Early Lung Cancer Works to Move the Field Forward
In 1999, a team of researchers from Weill Cornell Medical College advocated the use of a then-novel practice: low-dose radiation CT screening for lung cancer. It captures a full thoracic image in a single breath hold, and can recognize a tumor in its earliest stages when the chance for cure is...
A Call to Action for Oncology Clinicians to Help Patients ‘Move Through Cancer’
“There is clear evidence that patients are more likely to exercise if their oncologist tells them to do so,” reported representatives from 17 organizations participating in the Second Roundtable on Exercise and Cancer Prevention and Control. In an article published in CA: A Cancer Journal for...
Stanford Medicine Division of Oncology Welcomes Three New Faculty Members
The Stanford Medicine Department of Medicine is excited to welcome three faculty members to its Division of Oncology: Curtis Chong, MD, PhD; Fauzia Riaz, MD; and Shagufta Shaheen, MD. Each of these individuals brings an impressive record of academic pursuits focused on advancing care for and...
ACCC Presents Annual Achievement Award Posthumously to Arti Hurria, MD, FASCO
The 2019 Association of Community Cancer Centers (ACCC) Annual Achievement Award was presented posthumously to Arti Hurria, MD, FASCO, of City of Hope. The oncology community experienced a devastating loss with the untimely passing of Dr. Hurria in November 2018. Dr. Hurria was the George Tsai...
A Need for Human Connection Led to a Rewarding Career in Geriatric Oncology for Lodovico Balducci, MD
Older adults are the fastest-growing segment of our population, and more than 65% of patients with newly diagnosed cancer are 65 years of age or older. Although we now recognize the special needs of older patients with cancer, the field of geriatric oncology emerged quietly, with early growing...
An Oncologist’s Thoughtful Examination of Cancer and Personal Loss
“I could not have written this book when I was 30 years old. It is not because of any great discoveries I have made or research papers I have published since. It is because of the experience the intervening decades have given me as I cared for thousands of cancer patients and accompanied many to...
Navneet S. Majhail, MD, MS, Was Inspired by His Father’s Career as a Military Doctor and His Mother’s Battle With Cancer
In this installment of the Living a Full Life series, guest editor Jame Abraham, MD, FACP, spoke with Navneet S. Majhail, MD, MS, about his journey from India to the Cleveland Clinic, where he is Director of the Blood and Marrow Transplant Program. He is also President of the American Society for...
2019 Mary Pazdur Award for Excellence in Advanced Practice in Oncology
The Advanced Practitioner Society for Hematology and Oncology (APSHO) recently awarded the 2019 Mary Pazdur Award for Excellence in Advanced Practice in Oncology to Jody Pelusi, PhD, FNP, AOCNP (center). Dr. Pelusi is with HonorHealth Research Institute in Scottsdale. The award was presented...
Award Winners Named for 2019 San Antonio Breast Cancer Symposium
The San Antonio Breast Cancer Symposium (SABCS) and the American Association for Cancer Research (AACR) will honor two renowned researchers for their work in breast cancer at the 2019 SABCS, to be held December 10–14 in San Antonio. Myles Brown, MD, is the recipient of the 2019 AACR Distinguished ...
MD Anderson Names New Senior Vice President and Chief Legal Officer
The University of Texas MD Anderson Cancer Center has named Allyson Hancock Kinzel, JD, as Senior Vice President and Chief Legal Officer, effective November 1, 2019. Ms. Kinzel takes on this new role leading legal and regulatory affairs after serving as Chief Legal Officer since 2018. She will...
Maximizing Benefit in the Treatment of Immune-Mediated Colitis
Immune-related colitis is the second most common toxicity associated with checkpoint inhibitors, affecting up to 40% of patients. The ASCO Post interviewed Yinghong Wang, MD, PhD, Director of Medication-Induced Colitis and Enteritis, Director of Fecal Microbiota Transplantation, and Associate...
American Society for Dermatologic Surgery Awards Eight Research Grants
The American Society for Dermatologic Surgery (ASDS) has announced eight grant recipients across three research programs to support its mission to foster, develop, and encourage investigative knowledge in dermatologic surgery. Jumpstart Research Seed Grants Three Jumpstart Research Seed Grants were ...
City of Hope’s Michael Caligiuri, MD, Formally Appointed to Deana and Stave Campbell Physician-in-Chief Distinguished Chair
Michael A. Caligiuri, MD, President of City of Hope National Medical Center, in Duarte, California, has been appointed the Deana and Steve Campbell Physician-in-Chief Distinguished Chair in Honor of Alexandra Levine, MD. The position was created in honor of Dr. Levine, a City of Hope Professor of...
Breast Cancer Treatments Targeting Estrogen May Be Putting Patients at Risk for Long-Term Comorbidities
“The majority of breast cancers are hormone receptor–positive, and treatments that target the estrogen receptors are very effective, but they also cause havoc in many tissues that are dependent on estrogen for normal functioning. As a result, breast cancer survivors suffer from ongoing symptoms and ...
